These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 19668225

  • 1. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M.
    Oncogene; 2009 Oct 22; 28(42):3689-701. PubMed ID: 19668225
    [Abstract] [Full Text] [Related]

  • 2. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.
    He L, Lv S, Ma X, Jiang S, Zhou F, Zhang Y, Yu R, Zhao Y.
    Med Oncol; 2022 Jan 29; 39(4):45. PubMed ID: 35092510
    [Abstract] [Full Text] [Related]

  • 3. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W, Bisi J, Strum J, Liu L, Carrick K, Graham KM, Treece AL, Hardwicke MA, Dush M, Liao Q, Westlund RE, Zhao S, Bacus S, Spector NL.
    Cancer Res; 2006 Feb 01; 66(3):1640-7. PubMed ID: 16452223
    [Abstract] [Full Text] [Related]

  • 4. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.
    Mol Cancer Res; 2009 Feb 01; 7(2):275-84. PubMed ID: 19208749
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X, Gao L, Wang S, Lee CK, Ordentlich P, Liu B.
    Cancer Res; 2009 Nov 01; 69(21):8403-11. PubMed ID: 19826038
    [Abstract] [Full Text] [Related]

  • 8. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
    Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, Zabel BU.
    Cancer Res; 2006 Apr 01; 66(7):3715-25. PubMed ID: 16585198
    [Abstract] [Full Text] [Related]

  • 9. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK, Lee JJ, Yang Y, You KH, Lee JH.
    Carcinogenesis; 2008 Apr 01; 29(4):704-12. PubMed ID: 18258606
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, Chen C.
    Oncogene; 2009 Oct 22; 28(42):3702-13. PubMed ID: 19668233
    [Abstract] [Full Text] [Related]

  • 13. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
    Yong HY, Kim IY, Kim JS, Moon A.
    Int J Oncol; 2010 Feb 22; 36(2):501-7. PubMed ID: 20043086
    [Abstract] [Full Text] [Related]

  • 14. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T.
    Biochem J; 2003 Oct 01; 375(Pt 1):199-205. PubMed ID: 12841847
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
    Schulz R, Streller F, Scheel AH, Rüschoff J, Reinert MC, Dobbelstein M, Marchenko ND, Moll UM.
    Cell Death Dis; 2014 Jan 02; 5(1):e980. PubMed ID: 24384723
    [Abstract] [Full Text] [Related]

  • 17. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
    Tan M, Lan KH, Yao J, Lu CH, Sun M, Neal CL, Lu J, Yu D.
    Cancer Res; 2006 Apr 01; 66(7):3764-72. PubMed ID: 16585203
    [Abstract] [Full Text] [Related]

  • 18. Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.
    Shimizu H, Seiki T, Asada M, Yoshimatsu K, Koyama N.
    Oncogene; 2003 Feb 13; 22(6):831-9. PubMed ID: 12584562
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of lactate dehydrogenase-A by siRNAs for reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin.
    Kim SH, Lee GM.
    Appl Microbiol Biotechnol; 2007 Feb 13; 74(1):152-9. PubMed ID: 17086415
    [Abstract] [Full Text] [Related]

  • 20. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells.
    Noh EJ, Jang ER, Jeong G, Lee YM, Min CK, Lee JS.
    Cancer Res; 2005 Dec 15; 65(24):11400-10. PubMed ID: 16357148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.